|
HRGN Harvard Apparatus Regenerative Technology Inc 1563665 |
| Income Statement |
|
Revenue
|
form10-q
|
59,000 |
|
Net Income
|
form10-q
|
-1,860,000 |
|
Profit Margin
|
|
-3152.54% |
| Balance Sheet |
|
Current Assets
|
3,974,000 |
|
Assets
|
5,311,000 |
|
Current Liabilities
|
1,247,000 |
|
Liabilities
|
1,471,000 |
|
Equity
|
3,840,000 |
|
Shares Out
|
13,882,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-3,727,000 |
| Market Analysis |
Market Cap
|
74,103,460 |
|
Price
|
2.15 |
|
BVPS
|
0.28 |
|
PB
|
7.77 |
|
EPS
|
-0.60 |
|
PS
|
314.00 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HRGN documents filed with the SEC.
HRGN Filings
Clear
